These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8951490)

  • 1. Small cell carcinoma of the liver: a hitherto unreported variant of hepatocellular carcinoma.
    Zanconati F; Falconieri G; Lamovec J; Zidar A
    Histopathology; 1996 Nov; 29(5):449-53. PubMed ID: 8951490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-cell tumors of the liver: a cytological study of 91 cases and a review of the literature.
    Khalbuss WE; Grigorian S; Bui MM; Elhosseiny A
    Diagn Cytopathol; 2005 Jul; 33(1):8-14. PubMed ID: 15945087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma with an unusual neuroendocrine component.
    Yamaguchi R; Nakashima O; Ogata T; Hanada K; Kumabe T; Kojiro M
    Pathol Int; 2004 Nov; 54(11):861-5. PubMed ID: 15533230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
    Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
    Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell carcinoma of the liver: a case report.
    Kilinç N; Yalçin K; Değertekin H; Ozaydin M
    Turk J Gastroenterol; 2003 Sep; 14(3):211-4. PubMed ID: 14655070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues.
    Kitagawa Y; Iwai M; Muramatsu A; Tanaka S; Mori T; Harada Y; Okanoue T; Kashima K
    Histopathology; 2002 May; 40(5):472-9. PubMed ID: 12010368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoblastoma: an immunohistochemical and ultrastructural study.
    Abenoza P; Manivel JC; Wick MR; Hagen K; Dehner LP
    Hum Pathol; 1987 Oct; 18(10):1025-35. PubMed ID: 2443437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yolk sac tumor of the liver combined with hepatocellular carcinoma.
    Morinaga S; Nishiya H; Inafuku T
    Arch Pathol Lab Med; 1996 Jul; 120(7):687-90. PubMed ID: 8757478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
    Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
    Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
    Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic hepatocellular carcinoma of skin diagnosed with hepatocyte paraffin 1 and a-fetoprotein immunostainings.
    Terada T; Sugiura M
    Int J Surg Pathol; 2010 Oct; 18(5):433-6. PubMed ID: 18499685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
    Garcia MT; Bejarano PA; Yssa M; Buitrago E; Livingstone A
    Virchows Arch; 2006 Sep; 449(3):376-81. PubMed ID: 16896889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-cell neuroendocrine carcinoma of the ampullary region. A clinicopathologic, immunohistochemical, and ultrastructural study of three cases.
    Zamboni G; Franzin G; Bonetti F; Scarpa A; Chilosi M; Colombari R; Menestrina F; Pea M; Iacono C; Serio G
    Am J Surg Pathol; 1990 Aug; 14(8):703-13. PubMed ID: 1696069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma with neuroendocrine differentiation: a case report.
    Lu JG; Farukhi MA; Mayeda D; French SW
    Exp Mol Pathol; 2017 Oct; 103(2):200-203. PubMed ID: 28939160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
    Cho SJ; Ferrell LD; Gill RM
    Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.